Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
The Cannabist Company Holdings Inc. is a U.S.-based, vertically integrated cannabis company operating primarily in the regulated medical and adult-use cannabis markets. The company cultivates, manufactures, and retails cannabis products, with revenue driven mainly through retail dispensary sales, wholesale distribution, and branded product offerings. Its operations span multiple U.S. states with differing regulatory frameworks, serving both medical patients and adult-use consumers depending on jurisdiction.
Originally founded in 2012 as Columbia Care, the company was an early entrant into U.S. medical cannabis markets and built scale through disciplined expansion and acquisitions. In 2021, it rebranded to The Cannabist Company to align its corporate identity with its flagship retail brand. The company positions itself as a multi-state operator with an emphasis on operational efficiency, brand consistency, and compliance in highly regulated markets.
Business Operations
The company operates through vertically integrated business lines encompassing cultivation, processing, and retail distribution. Its primary business segments include Retail Dispensaries, Cultivation & Manufacturing, and Wholesale & Branded Products, generating revenue from direct-to-consumer sales and third-party distribution. The company controls cultivation and processing assets designed to supply both its own dispensaries and external wholesale customers.
Operations are primarily domestic within the United States, with assets and licenses across multiple state markets. The company owns and operates dispensaries under The Cannabist retail brand and manages a portfolio of in-house product brands. Subsidiaries and licensed operating entities are structured to comply with individual state regulatory requirements, a standard approach within the U.S. cannabis industry.
Strategic Position & Investments
The Cannabist Company’s strategy has historically focused on building scale in limited-license and high-population states while maintaining capital discipline. Growth initiatives have included selective acquisitions, organic expansion of cultivation capacity, and optimization of retail footprints to improve profitability and cash flow. The company has also emphasized cost containment and balance sheet management amid broader industry pricing pressure.
Notable past acquisitions include Green Leaf Medical and The Green Solution, which expanded the company’s presence in key U.S. markets. The company invests in product development across flower, edibles, concentrates, and wellness-oriented cannabis products, while monitoring emerging opportunities such as cannabinoid-based formulations. Data inconclusive based on available public sources regarding material investments outside core cannabis operations.
Geographic Footprint
The Cannabist Company operates across several U.S. states, with a footprint concentrated in Northeast, Midwest, Mid-Atlantic, South, and Western United States markets. Key operational states have included New York, New Jersey, Florida, Pennsylvania, Virginia, Arizona, and Ohio, among others, subject to regulatory approvals and license status.
Headquartered in New York, United States, the company’s geographic diversification is intended to mitigate regulatory and market risk while providing exposure to both mature and emerging cannabis markets. All operations are domestic; there is no verified evidence of active international cultivation or retail operations based on available public disclosures.
Leadership & Governance
The Cannabist Company is led by an executive team with experience in regulated industries, healthcare, consumer goods, and capital markets. Leadership has articulated a strategic vision centered on disciplined growth, regulatory compliance, and operational efficiency in a challenging macroeconomic and capital-constrained environment.
Key executives include:
- David Hart – Chief Executive Officer
- John DeFeo – Chief Financial Officer
- Allan Whitten – Chief Operating Officer
- Beth Stavola – Founder and Strategic Advisor
- Ryan Stump – Chief Accounting Officer
The company operates under a board-governed structure consistent with public company standards, with oversight of strategy, risk management, and executive performance.